Drugs / H7N9 pLAIV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02957656 | Dec 2016 → Jun 2018 | — | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H7N9 pLAIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02957656 ↗ |
| Modality | Vaccine | “H7N9 pandemic live attenuated influenza vaccine (H7N9 pLAIV)” NCT02957656 ↗ |